Every new appointment to a board of directors says something about the company that makes the appointment, and they all need to start adding more diverse people to their boards every year. Clay Siegall has been named to the board of directors at Mirna Therapeutics because he has already had success at Seattle Genetics. Clay Siegall founded Seattle Genetics because he needed a place to sell and market his antibody therapies, and he has grown the brand to include a stock symbol and millions in sales.
Clay Siegall has been able to help people with cancer treatments, and he wants to be sure that people can get better drugs at trial. His company is doing about $100 million in sales in a year in very good trial rounds, and he can offer advice to Mirna Therapeutics that will help the company get through their trials in about the same way. They are going to benefit from having someone on the level of Clay Siegall on their board, and they might even be able to partner in the future.
Clay Siegall also knows how to get more private funding and get his company to have a higher stock price. He knows how to handle these things even though he is a scientist, and he can help teach the people at Mirna Therapeutics what is possible. That is why he is the new member of the board at a company that is growing a lot.
There are a lot of people who will be healed by those at Seattle Genetics and Mirna Therapeutics. These people get services that are all based on good experience, and Clay Siegall brings a lot of that experience to the people at Mirna Therapeutics. These people are going to be saved with a partnership like this on the books.
Learn More here: